Anzeige
Mehr »
Login
Montag, 27.09.2021 Börsentäglich über 12.000 News von 673 internationalen Medien
LUKRATIVE NEUVORSTELLUNG IM MEGA-WACHSTUMSMARKT
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PNTA ISIN: US09076G1040 Ticker-Symbol: 6XBA 
Frankfurt
24.09.21
09:24 Uhr
6,723 Euro
-0,036
-0,53 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOPHYTIS ADR Chart 1 Jahr
5-Tage-Chart
BIOPHYTIS ADR 5-Tage-Chart

Aktuelle News zur BIOPHYTIS ADR Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
BIOPHYTIS ADR Aktie jetzt für 0€ handeln
17.09.Biophytis reports 1H results2
17.09.BIOPHYTIS SA: Biophytis Reports H1 2021 Financial Results and Provides Business Update2
15.09.Biophytis SA - 6-K, Report of foreign issuer1
15.09.Biophytis shares rise 10% after DMC recommendation for Phase 2-3 COVID-19 study2
15.09.Press Release: Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 COVA Study With Sarconeos (BIO101) in COVID-191
15.09.BIOPHYTIS SA: Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 COVA Study With ...-
14.09.BIOPHYTIS SA: Biophytis to Attend Key Upcoming Investor Events and Industry Conferences-
09.09.New medical chief at Biophytis-
09.09.BIOPHYTIS SA: Biophytis Leadership is Reinforced With New Chief Medical Officer Appointment-
17.08.Biophytis SA - 6-K, Report of foreign issuer2
16.08.DMC Recommends Biophytis Continue Sarconeos COVID-19 Study-
16.08.Biophytis receives favorable DMC recommendation for late-stage Sarconeos study in COVID-191
16.08.BIOPHYTIS SA: Biophytis Receives Favorable Recommendation From Data Monitoring Committee (DMC) Based on Safety Analysis of Sarconeos (BIO101) to Continue ...2
13.08.BIOPHYTIS SA: Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March ...2
02.08.Biophytis Stock Gains As Sarconeos High Dose Improves Gait Speed Versus Placebo In Patients With Muscle Loss Due To Aging1
02.08.Biophytis reports top line results of Phase 2 Sarconeos study in sarcopenia4
02.08.BIOPHYTIS SA: Biophytis Announces Top Line Results of SARA-INT Phase 2 Study With Sarconeos (BIO101) in Sarcopenia4
20.07.Biophytis SA - 6-K, Report of foreign issuer-
19.07.BIOPHYTIS SA: Judgment Rendered on July 16, 2021 in the Proceedings Between Biophytis and Negma Group Ltd by the Execution Judge From the Paris Court ...5
12.07.Biophytis Stock Is Trading Higher On Encouraging Preclinical Data From COVID-19 Study With Sarconeos1
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1